Epidermal graft in stable vitiligo
Phase 2
- Conditions
- Vitiligo and other depigmented lesions.Vitiligo
- Registration Number
- IRCT138802251906N1
- Lead Sponsor
- Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
depigmented lesions unresponsive to medications and phototherapy; all patients had stable disease for more than 1 year and there was not any history of a positive Kobner phenomenon.
Exclusion criteria: unstable or active vitiligo; positve Kobner phenomenon; age under 12 years old and pregnancy.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Repigmentation rate. Timepoint: Every week in the first month and once a month for the following 6-8 months. Method of measurement: The repigmentation rate of lesions was classified as excellent (more than 75% repigmentation), good (50-75% repigmentation), moderate (25-50% repigmentation) and poor (less than 25% repigmentation).
- Secondary Outcome Measures
Name Time Method Perigraft halo. Timepoint: All patients were visited every week in the first month and once a month for the following 6-8 months. Method of measurement: clinical observation.;Scar and Keloid. Timepoint: All patients were visited every week in the first month and once a month for the following 6-8 months. Method of measurement: clinical observation.;Kobner phenomen. Timepoint: All patients were visited every week in the first month and once a month for the following 6-8 months. Method of measurement: clinical observation.;Color mismatch. Timepoint: All patients were visited every week in the first month and once a month for the following 6-8 months. Method of measurement: clinical observation.;Infection. Timepoint: All patients were visited every week in the first month and once a month for the following 6-8 months. Method of measurement: clinical observation and Labratory assesment.